Jianshan Mo

Inhibition of STAT3-ferroptosis negative regulatory axis suppresses tumor growth and alleviates chemoresistance in gastric cancer

Shumin Ouyang, Huaxuan Li, Linlin Lou et al. · Redox Biology · 2022 · 489 citations · Full text

Medicine, Oncology, Pharmacology +14

A novel STAT3 inhibitor W2014-S regresses human non-small cell lung cancer xenografts and sensitizes EGFR-TKI acquired resistance

Qiyao Zheng, Hui Dong, Jianshan Mo et al. · Theranostics · 2020 · 109 citations · Full text

Medicine, Oncology, Pharmacology +15

The novel STAT3 inhibitor WZ-2-033 causes regression of human triple-negative breast cancer and gastric cancer xenografts

Yan Zhong, Shuo Shi, Qiuyao Huang et al. · Acta Pharmacologica Sinica · 2021 · 36 citations · Full text

Medicine, Oncology, Pharmacology +9

Discovery and Optimization of Novel Biphenyl Derivatives Bearing Cyclopropyl Linkage as Potent Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Inhibitors

Tongfei Jing, Zhijing Zhang, Zhenghui Kang et al. · Journal of Medicinal Chemistry · 2023 · 23 citations

Pharmacy, Medicinal Chemistry, Pharmacology +14

Metabolic reprogramming of tumor-associated macrophages via adenosine-A2AR signaling drives cross-resistance in non-small cell lung cancer

Wen Ding, Jianshan Mo, Yingxue Su et al. · Drug Resistance Updates · 2025 · 15 citations

Medicine, Cancer Biology, Oncology +17